PLK1 and neoplasm: Promising tumour regression was reported after synergistic effects of a mitotic inhibitor acting on PLK1 (BI2536) to induce mitotic arrest, and a proapoptotic agent (LCL161) to sensitize HCC cells to TNFα-triggered cell death in a murine model of HCC [83].